Lurbinectedin as Second- or Third-Line Palliative Therapy in Malignant Pleural Mesothelioma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
Only registered members have full access to PracticeUpdate content.